|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 270, Issue 3 1091-H1100, Copyright © 1996 by American Physiological Society
ARTICLES |
A. M. Gunteski-Hamblin, G. Song, R. A. Walsh, M. Frenzke, G. P. Boivin, G. W. Dorn 2nd, M. A. Kaetzel, N. D. Horseman and J. R. Dedman
Department of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, Ohio 45267-0576, USA.
Annexin VI is a member of a family of Ca(2+)-dependent phospholipid-binding proteins that is expressed in many tissues, including the heart. It is a regulator of membrane-associated events, including the skeletal muscle ryanodine-sensitive Ca2+ release channel and the cardiac Na+/Ca2+ exchanger. The potential roles of annexin VI in Ca2+ signaling in cardiac myocytes were evaluated by targeting its overexpression to the hearts of transgenic mice. Expression of full-length human annexin VI cDNA was targeted to the heart using the alpha-myosin heavy chain gene promoter (Subramaniam, A., W. K. Jones, J. Gulick, S. Wert, J. Neumann, and J. Robbins. J. Biol. Chem. 266: 24613-24620, 1991). Five transgenic lines exhibited at least 10-fold overexpression of annexin VI protein in both atria and ventricles. Pathological evaluation indicated mice overexpressing annexin VI had enlarged dilated hearts, acute diffuse myocarditis, lymphocytic infiltration, moderate to severe fibrosis throughout the heart, and mild fibrosis around the pulmonary veins of the lungs. Contractile mechanics of cardiomyocytes isolated from hearts of transgenic animals showed frequency-dependent reduced percent shortening and decreased rates of contraction and relaxation compared with control animals. Cardiomyocytes isolated from transgenic animals had lower basal levels of intracellular free Ca2+ and a reduced rise in free Ca2+ following depolarization. After stimulation, intracellular free Ca2+ returned to basal levels faster in transgenic cells than in cells from control animals. These data demonstrate that the overexpression of annexin VI in the heart disrupts normal Ca2+ homeostasis and suggests that this dysfunction may be due to annexin VI regulation of pumps and/or exchangers in the membranes of cardiomyocytes.
This article has been cited by other articles:
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chang, C. Sutherland, E. Hesse, R. Winkfein, W. B. Wiehler, M. Pho, C. Veillette, S. Li, D. P. Wilson, E. Kiss, et al. Identification of a novel interaction between the Ca2+-binding protein S100A11 and the Ca2+- and phospholipid-binding protein annexin A6 Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1417 - C1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gerke and S. E. Moss Annexins: From Structure to Function Physiol Rev, April 1, 2002; 82(2): 331 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Herr, N. Smyth, S. Ullrich, F. Yun, P. Sasse, J. Hescheler, B. Fleischmann, K. Lasek, K. Brixius, R. H. G. Schwinger, et al. Loss of Annexin A7 Leads to Alterations in Frequency-Induced Shortening of Isolated Murine Cardiomyocytes Mol. Cell. Biol., July 1, 2001; 21(13): 4119 - 4128. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Babiychuk and A. Draeger Annexins in Cell Membrane Dynamics: Ca2+-regulated Association of Lipid Microdomains J. Cell Biol., September 5, 2000; 150(5): 1113 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takeishi, P. Ping, R. Bolli, D. L. Kirkpatrick, B. D. Hoit, and R. A. Walsh Transgenic Overexpression of Constitutively Active Protein Kinase C {epsilon} Causes Concentric Cardiac Hypertrophy Circ. Res., June 23, 2000; 86(12): 1218 - 1223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Hawkins, J. Roes, D. Rees, J. Monkhouse, and S. E. Moss Immunological Development and Cardiovascular Function Are Normal in Annexin VI Null Mutant Mice Mol. Cell. Biol., December 1, 1999; 19(12): 8028 - 8032. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. FREY, B. F. X. REBER, B. S. VISHWANATH, G. ESCHER, and F. J. FREY Annexin I modulates cell functions by controlling intracellular calcium release FASEB J, December 1, 1999; 13(15): 2235 - 2245. [Abstract] [Full Text] |
||||
![]() |
P. Trouve, S. Legot, I. Belikova, F. Marotte, D. Benevolensky, F. Russo-Marie, J.-L. Samuel, and D. Charlemagne Localization and quantitation of cardiac annexins II, V, and VI in hypertensive guinea pigs Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1159 - H1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Loukianov, Y. Ji, I. L. Grupp, D. L. Kirkpatrick, D. L. Baker, T. Loukianova, G. Grupp, J. Lytton, R. A. Walsh, and M. Periasamy Enhanced Myocardial Contractility and Increased Ca2+ Transport Function in Transgenic Hearts Expressing the Fast-Twitch Skeletal Muscle Sarcoplasmic Reticulum Ca2+-ATPase Circ. Res., November 2, 1998; 83(9): 889 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Pawloski-Dahm, G. Song, D. L. Kirkpatrick, J. Palermo, J. Gulick, G. W. Dorn II, J. Robbins, and R. A. Walsh Effects of Total Replacement of Atrial Myosin Light Chain-2 With the Ventricular Isoform in Atrial Myocytes of Transgenic Mice Circulation, April 21, 1998; 97(15): 1508 - 1513. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |